Technical Analysis for BLUE - bluebird bio, Inc.

Grade Last Price % Change Price Change
grade C 175.95 -3.38% -6.15
BLUE closed down 3.38 percent on Friday, January 19, 2018, on 82 percent of normal volume.
13 Watchers
Track This Stock
Watchlist Portfolio

Trend Table & Recent Alerts
ADX Long-Term Intermediate-Term Short-Term
Weak or Absent Up Up Up
See historical BLUE trend table...

Date Alert Name Type % Chg
Jan 19 Multiple of Ten Bearish Other 0.00%
Jan 19 Inside Day Range Contraction 0.00%
Jan 19 Wide Bands Range Expansion 0.00%
Jan 18 MACD Bullish Centerline Cross Bullish -3.38%
Jan 18 Multiple of Ten Bullish Other -3.38%
Jan 18 Wide Bands Range Expansion -3.38%
Jan 18 Overbought Stochastic Strength -3.38%
Jan 17 Crossed Above 50 DMA Bullish 0.40%
Jan 17 Expansion Pivot Buy Setup Bullish Swing Setup 0.40%
Jan 17 Multiple of Ten Bearish Other 0.40%

Older signals for BLUE ...

Get a Trading Assistant

Let us help you stay on top of your investments. We will alert you to important technical developments on your portfolio & watchlist.
Configure default chart indicators
Basic chart:

Profile
bluebird bio, Inc., a clinical-stage biotechnology company, focuses on the development, manufacture, and marketing of therapies to treat various human diseases. Its product candidates include Lenti-D to treat patients with childhood cerebral adrenoleukodystrophy (ALD), a hereditary neurological disorder, as well as for the treatment of adult cerebral ALD; and CAR T cells products for treating oncology diseases. The company's product candidates also comprise LentiGlobin vector for the treatment of ß-thalassemia, a hereditary blood disorder; and sickle cell diseases. It has a strategic collaboration with Celgene Corporation to discover, develop, and commercialize disease-altering gene therapies in oncology. The company was formerly known as Genetix Pharmaceuticals, Inc., and changed its name to bluebird bio, Inc. in September 2010. bluebird bio, Inc. was founded in 1992 and is headquartered in Cambridge, Massachusetts.
Is BLUE a Buy, Sell or Hold?
Indicator Bull Case Neutral / Hold Bear Case
50 DMA
200 DMA
ADX Trend
Oversold / Overbought
Relative Strength
Summary: Counts: 2 bullish, 0 bearish and 3 neutral indicators. You may wish to incorporate that into your trading strategies.
Indicators
Indicator Value
52 Week High 222.03
52 Week Low 64.65
Average Volume 896,179
200-Day Moving Average 123.1271
50-Day Moving Average 171.3954
20-Day Moving Average 176.6625
10-Day Moving Average 172.555
Average True Range 8.0351
ADX 17.53
+DI 20.4
-DI 22.67
Chandelier Exit (Long, 3 ATRs ) 163.6047
Chandelier Exit (Short, 3 ATRs ) 185.2553
Upper Bollinger Band 187.8472
Lower Bollinger Band 165.4778
Percent B (%b) 0.47
BandWidth 12.662223
MACD Line 0.3223
MACD Signal Line 0.8389
MACD Histogram -0.5166
Fundamentals Value
Market Cap 8.02 Billion
Num Shares 45.6 Million
EPS -7.33
Price-to-Earnings (P/E) Ratio -24.00
Price-to-Sales 233.66
Price-to-Book 5.18
PEG Ratio 0.31
Dividend 0.00
Dividend Yield 0.00%
Pivot Point Level Traditional / Classic Fibonacci Demark Woodie Camarilla
Resistance 4 (R4) 185.85
Resistance 3 (R3) 186.80 184.45 184.20
Resistance 2 (R2) 184.45 181.93 183.98 183.65
Resistance 1 (R1) 180.20 180.37 179.03 179.25 183.10
Pivot Point 177.85 177.85 177.26 177.38 177.85
Support 1 (S1) 173.60 175.33 172.43 172.65 168.80
Support 2 (S2) 171.25 173.77 170.78 168.25
Support 3 (S3) 167.00 171.25 167.70
Support 4 (S4) 166.05